|
|
Article: Citalopram: New SSRI for Treatment of Depression.
- Article from:
- Family Practice Alert
- Article date:
- October 1, 1998
CopyrightCOPYRIGHT 1998 AHC Media LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Pharmacology Update
Citalopram: New SSRI for Treatment of Depression
By William T. Elliott, MD, and James Chan, PharmD, PhD
Anew selective serotonin reuptake inhibitor (SSRI), citalopram, was approved by the FDA in July for the treatment of depression. The drug is to be marketed under the trade name Celexa by Forest Laboratories and Parke-Davis. It is the fifth SSRI to be approved for use in this country, joining fluoxetine, paroxetine, sertraline, and fluvoxamine. Its action appears to be limited to the potentiation of serotonergic activity in the central nervous system, with minimal effect on norepinephrine and dopamine transmitter ...